부산대학교 도서관

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.genhosppsych.2007.03.008 Byline: Seth Himelhoch (a), Geetanjali Chander (b), John A. Fleishman (c), James Hellinger (d), Paul Gaist (e), Kelly A. Gebo (b) Keywords: HAART; Inpatient medical hospital services; HIV-infected patients Abstract: Among HIV-infected individuals, we examined whether having co-occurring serious mental illness (SMI) and injection drug use (IDU) impacts: (a) receipt of highly active antiretroviral therapy (HAART), and (b) utilization of inpatient HIV services, compared to those who have SMI only, IDU only or neither SMI nor IDU. Author Affiliation: (a) Division of Services Research, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD 21212, USA (b) Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA (c) Agency for Healthcare Research and Quality, Rockville, MD, USA (d) Tufts University, Boston, MA, USA (e) Office of AIDS Research, National Institute of Health, Bethesda, MD, USA Article History: Received 21 June 2006; Accepted 26 March 2007 Article Note: (footnote) [star] Disclaimer: The views expressed in this paper are those of the authors. No official endorsement by the Department of Health and Human Services, the National Institutes of Health, or the Agency for Healthcare Research and Quality is intended or should be inferred.